Comera Life Sciences Holdings, Inc. (CMRA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: May 9, 2025

CMRA Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2022 FY 2021 FY 2020
Period Ending
Dec '22 Dec '21 Dec '20
Revenue
0.630.320.44
Revenue Growth (YoY)
97.95%-27.79%-
Cost of Revenue
0.210.160.1
Gross Profit
0.420.160.34
Selling, General & Admin
9.324.11.2
Research & Development
1.571.61.26
Operating Expenses
10.895.692.47
Operating Income
-10.47-5.54-2.13
Interest Expense
-0.02--
Other Non Operating Income (Expenses)
-5.59--0.13
EBT Excluding Unusual Items
-16.08-5.54-2.26
Other Unusual Items
-2.090.08-
Pretax Income
-18-5.45-2.13
Net Income
-18-5.45-2.13
Preferred Dividends & Other Adjustments
0.37--
Net Income to Common
-18.38-5.45-2.13
Shares Outstanding (Basic)
10311
Shares Outstanding (Diluted)
10311
Shares Change (YoY)
246.97%-72.74%-
EPS (Basic)
-1.76-1.81-0.19
EPS (Diluted)
-1.76-1.81-0.19
Free Cash Flow
-9.8-3.9-1.82
Free Cash Flow Per Share
-0.94-1.29-0.16
Gross Margin
66.77%49.66%76.43%
Operating Margin
-1653.76%-1730.79%-480.34%
Profit Margin
-2902.84%-1704.58%-479.88%
Free Cash Flow Margin
-1547.99%-1219.38%-410.11%
EBITDA
-10.38-5.45-2.04
D&A For EBITDA
0.090.090.09
EBIT
-10.47-5.54-2.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.